Luvida | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

119 results for “Luvida”

Trials

View all 75 →

Not yet recruiting

The Lucida Project

1,500 participants · First posted Jul 1, 2026

Europe-Africa Research Network for Evaluation of Second-line Therapy

1,277 participants · First posted Oct 1, 2009

Lleida TIA Intervention Study

100 participants · First posted Aug 24, 2020

Drugs

View all 11 →

FLUVID

Ruvidar

Manufacturer: Theralase Technologies Inc.

Conditions: BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) Carcinoma In-Situ (CIS)

Lucid-MS

Organizations

View all 10 →

Sumida

AqVida GmbH

Germany

University of Lleida

Spain

News

View all 23 →

AI Is Already Transforming Oncology Drug Design and Clinical Trials, AstraZeneca's Reis-Filho Tells AACR

Guided Therapeutics Secures $700,000 Order for LuViva Cervical Cancer Screening Systems in China

Guided Therapeutics Advances China Expansion with New Distribution Agreement and Purchase Order Payments for LuViva Cervical Scan

Page 1 of 12